- Home
- JVA vs CGTX Comparison
JVA vs CGTX Comparison
Compare JVA & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JVA
- CGTX
- Stock Information
- Founded
- JVA 1971
- CGTX 2007
- Country
- JVA United States
- CGTX United States
- Employees
- JVA N/A
- CGTX 25
- Industry
- JVA Packaged Foods
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- JVA Consumer Staples
- CGTX Health Care
- Exchange
- JVA Nasdaq
- CGTX Nasdaq
- Market Cap
- JVA 19.5M
- CGTX 23.1M
- IPO Year
- JVA 2005
- CGTX 2021
- Fundamental
- Price
- JVA $3.62
- CGTX $0.41
- Analyst Decision
- JVA
- CGTX Strong Buy
- Analyst Count
- JVA 0
- CGTX 5
- Target Price
- JVA N/A
- CGTX $7.13
- AVG Volume (30 Days)
- JVA 154.4K
- CGTX 515.1K
- Earning Date
- JVA 06-16-2025
- CGTX 05-06-2025
- Dividend Yield
- JVA N/A
- CGTX N/A
- EPS Growth
- JVA 6252.13
- CGTX N/A
- EPS
- JVA 0.53
- CGTX N/A
- Revenue
- JVA $80,327,181.00
- CGTX N/A
- Revenue This Year
- JVA N/A
- CGTX N/A
- Revenue Next Year
- JVA N/A
- CGTX N/A
- P/E Ratio
- JVA $6.37
- CGTX N/A
- Revenue Growth
- JVA 15.77
- CGTX N/A
- 52 Week Low
- JVA $1.23
- CGTX $0.31
- 52 Week High
- JVA $9.93
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- JVA 46.53
- CGTX 47.57
- Support Level
- JVA $3.15
- CGTX $0.35
- Resistance Level
- JVA $3.73
- CGTX $0.39
- Average True Range (ATR)
- JVA 0.33
- CGTX 0.03
- MACD
- JVA 0.12
- CGTX 0.01
- Stochastic Oscillator
- JVA 88.78
- CGTX 78.68
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.